Genetic evidence for GLP-1 and GIP receptors as targets for treatment and prevention of MASLD/MASH
This product is not a drug, food, or cosmetic and may not be misbranded, misused or mis-labled as a drug, food or cosmetic
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context by revealing your predispositions in key GLP-1 signaling pathwaysincluding GLP1R, GIPR, FTO, and MC4R variants
Nephrol Dial Transplant 2017;32:97-110.ArticlePubMed 27
That is not a microdose
#GLP1 #MetabolicHealth #WeightManagement #Nutraceuticals #BotanicalExtracts #GreenCoffeeBean #ChlorogenicAcid #NaturalAlternatives #ObesityManagement #SupplementScience #DrugDiscontinuation #SustainableWeightLoss #EvidenceBasedNutrition #ProductDevelopment #FormulationScience #PreventiveNutrition #MetabolicSupport #FunctionalIngredients #ClinicalNutrition #PostGLP1 #WeightRegain #NutraceuticalInnovation #PharmaTransition #HerbalMedicine #WellnessScience To view or add a comment, sign in New Clinical on High-Dose Safety Profile for Ashwagandha Root Extract A recent prospective, non-comparative clinical trial published in Frontiers in Nutrition evaluated the safety and tolerability of a standardized Ashwagandha (Withania somnifera) root extract (KSM-66 Ashwagandha) at a high dose of 2,000 mg/day over a 12-week period
